Yayın:
New combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells

Basit öğe sayfası
dc.contributor.authorKucuksayan, Ertan
dc.contributor.authorBozkurt, Fatih
dc.contributor.authorOzben, Tomris
dc.contributor.authorCicek, Perihan Kubra
dc.contributor.authorHanikoglu, Aysegul
dc.contributor.authorYilmaz, Mustafa Tahsin
dc.date.accessioned2026-06-27T14:06:11Z
dc.date.issued2017
dc.description.urihttps://doi.org/10.1016/j.jbiotec.2017.06.670
dc.identifier.doi10.1016/j.jbiotec.2017.06.670
dc.identifier.eissn1873-4863
dc.identifier.endpageS36
dc.identifier.issn0168-1656
dc.identifier.startpageS36
dc.identifier.urihttps://hdl.handle.net/20.500.14981/57027
dc.identifier.volume256
dc.identifier.wos000413585400106
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.conferenceEuropean Biotechnology Congress
dc.relation.ispartofJOURNAL OF BIOTECHNOLOGY
dc.subjectBiotechnology & Applied Microbiology
dc.titleNew combination strategy of doxorubicin and epoxomicin in biocompatibility: Biodegradable polymeric nanoparticles increase apoptosis in breast cancer cells
dc.typeMeeting Abstract
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar